Literature DB >> 3496136

CFU-F circulating in cord blood.

G Prindull, Z Ben-Ishay, W Ebell, M Bergholz, T Dirk, B Prindull.   

Abstract

CFU-F (colony forming units-fibroblast) were studied from cord blood and, as controls, from normal bone marrow of older children and adults. Numbers of CFU-F in cord blood buffy coat cells are lower by a factor of 10 in comparison to bone marrow CFU-F. Cytomorphology and staining with monoclonal antibody identify the progeny cells of CFU-F as fibroblasts. Cord blood CFU-F derived fibroblasts have properties supporting hematopoiesis: They produce CSF (colony stimulating factor) to which fresh cord blood CFU-GM (colony forming units-granulocytic, monocytic) react by colony formation in a dose-response manner. In addition, fibroblast colonies discharge clonogenic round cells into the medium forming CFU-GM and CFU-F colonies in secondary methyl cellulose cultures. We conclude that fetal blood contains clonogenic stromal cells (CFU-F) that give rise to fibroblasts with properties of hematopoietic support.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496136     DOI: 10.1007/BF00626017

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  37 in total

1.  Formation in agar of fibroblast-like colonies by cells from the mouse pleural cavity and other sources.

Authors:  D Metcalf
Journal:  J Cell Physiol       Date:  1972-12       Impact factor: 6.384

2.  Characterization of canine fetal lymphohematopoiesis: studies of CFUGM, CFUL, and CFUF.

Authors:  A K Klein; J A Dyck; K A Stitzel; J Shimizu; L A Fox; N Taylor
Journal:  Exp Hematol       Date:  1983-04       Impact factor: 3.084

3.  Morphological studies on 'adherent cells' in bone marrow cultures from humans, dogs, and mice.

Authors:  F D Wilson; M Tavassoli; B R Greenberg; D Hinds; A K Klein
Journal:  Stem Cells       Date:  1981       Impact factor: 6.277

4.  Haematopoietic stem cells (CFUc) in human cord blood.

Authors:  G Prindull; B Prindull; N Meulen
Journal:  Acta Paediatr Scand       Date:  1978-07

5.  The origin of the hematopoietic microenvironment in continuous bone marrow culture.

Authors:  S A Bentley; T Knutsen; J Whang-Peng
Journal:  Exp Hematol       Date:  1982-04       Impact factor: 3.084

6.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

7.  Migration of fibroblastoid stromal cells in murine blood.

Authors:  A H Piersma; R E Ploemacher; K G Brockbank; P G Nikkels; C P Ottenheim
Journal:  Cell Tissue Kinet       Date:  1985-11

8.  Circulating haematopoietic stem cells (CFUc) in healthy and diseased pre-term infants.

Authors:  G Prindull; M Albani; B Prindull; W Schröter
Journal:  Scand J Haematol       Date:  1980-09

9.  A monokine regulates colony-stimulating activity production by vascular endothelial cells.

Authors:  G C Bagby; E McCall; K A Bergstrom; D Burger
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

10.  In vitro analysis of the contributions of adherent cell layer and recharging population to hemopoietic cell proliferation in long-term bone marrow cultures.

Authors:  I Fabian; M Cline
Journal:  Exp Hematol       Date:  1981-04       Impact factor: 3.084

View more
  4 in total

1.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 2.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

3.  Pre CFU-F in bone marrow cultures from children with hematopoietic disease including acute leukemia.

Authors:  G Prindull; Z Ben-Ishay; B Prindull
Journal:  Blut       Date:  1987-12

Review 4.  The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu.

Authors:  Armita Mahdavi Gorabi; Maciej Banach; Željko Reiner; Matteo Pirro; Saeideh Hajighasemi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-09-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.